Understanding the impact of complicated grief on combat related posttraumatic stress disorder, guilt, suicide, and functional impairment in a clinical trial of post-9/11 service members and veterans.
Understanding the impact of complicated grief on combat related posttraumatic stress disorder, guilt, suicide, and functional impairment in a clinical trial of post-9/11 service members and veterans.
复制标题
在一项针对 9/11 后服役人员和退伍军人的临床试验中,了解复杂的悲伤对与战斗相关的创伤后应激障碍、内疚、自杀和功能障碍的影响。
DOI:
10.1002/da.22911
复制
发表时间:
2020
影响因子:
7.4
通讯作者:
Rauch,She
中科院分区:
文献类型:
--
作者:
Simon,NaomiM;Hoeppner,SusanneS;Lubin,RebeccaE;Robinaugh,DonaldJ;Malgaroli,Matteo;Norman,SonyaB;Acierno,Ron;Goetter,ElizabethM;Hellberg,SamanthaN;Charney,MeredithE;Bui,Eric;Baker,AmandaW;Smith,Erin;Kim,HMyra;Rauch,She
BackgroundComplicated grief (CG) is a bereavement‐specific syndrome distinct from but commonly comorbid with posttraumatic stress disorder (PTSD). While bereavement is common among military personnel (Simon et al., 2018), there is little research on the impact of CG comorbidity on PTSD treatment outcomes.MethodsTo evaluate the impact of comorbid CG on PTSD treatment outcomes we analyzed data from a randomized trial comparing prolonged exposure, sertraline, and their combination in veterans with a primary diagnosis of combat‐related PTSD (n= 194). Assessment of PTSD, trauma‐related guilt, functional impairment, and suicidal ideation and behavior occurred at baseline and weeks 6, 12, and 24 during the 24‐week trial.ResultsCG was associated with lower PTSD treatment response (odds ratio (OR) = 0.29, 95% confidence interval (CI) [0.12, 0.69],p= 0.005) and remission (OR = 0.28, 95% CI [0.11, 0.71],p= 0.007). Those with CG had greater severity of PTSD (p= 0.005) and trauma‐related guilt (<0.001) at baseline and endpoint. In addition, those with CG were more likely to experience suicidal ideation during the study (CG: 35%, 14/40 vs. no CG 15%, 20/130; OR = 3.01, 95% CI [1.29, 7.02],p= 0.011).ConclusionsComorbid CG is associated with elevated PTSD severity and independently associated with poorer endpoint treatment outcomes in veterans with combat‐related PTSD, suggesting that screening and additional intervention for CG may be needed.